Maurer M

Title : Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands - Wang_2022_Front.Immunol_13_955161

Author(s) : Wang Y , Scheffel J , Vera CA , Liu W , Gunzel D , Terhorst-Molawi D , Maurer M , Altrichter S

Ref : Front Immunol , 13 :955161 , 2022

PubMedID: 35967390

Title : Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria -

Author(s) : Koch K , Weller K , Werner A , Maurer M , Altrichter S

Ref : J Allergy Clin Immunol , 138 :1483 , 2016

PubMedID: 27496595

Title : Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients - Maurer_2013_Mult.Scler_19_631

Author(s) : Maurer M , Ortler S , Baier M , Meergans M , Scherer P , Hofmann W , Tracik F

Ref : Mult Scler , 19 :631 , 2013

PubMedID: 23069874

Maurer M

References (3)

1. Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands - Wang_2022_Front.Immunol_13_955161

2. Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria -

3. Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients - Maurer_2013_Mult.Scler_19_631